Taken together, these results suggest that the role of Akt/mTOR and ERK pathways in progranulin related signal transduction is still important in hematopoietic cancer cells, and progranulin is one of the attractive targets to suppress both pathways simultaneously. The gene discussed is GRN; the disease is hematopoietic and lymphoid cell neoplasm.